Xencor
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Xencor and other ETFs, options, and stocks.About XNCR
Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions.
XNCR Key Statistics
Stock Snapshot
With a market cap of 1.13B, Xencor(XNCR) trades at $15.45. The stock has a price-to-earnings ratio of -9.32.
During the trading session on 2025-12-17, Xencor(XNCR) shares reached a daily high of $16.89 and a low of $15.45. At a current price of $15.45, the stock is 0.0% higher than the low and still -8.5% under the high.
Trading volume for Xencor(XNCR) stock has reached 674.85K, versus its average volume of 805.77K.
Over the past 52 weeks, Xencor(XNCR) stock has traded between a high of $25.54 and a low of $6.92.
Over the past 52 weeks, Xencor(XNCR) stock has traded between a high of $25.54 and a low of $6.92.
XNCR News
Barclays raised the firm’s price target on Xencor (XNCR) to $26 from $23 and keeps an Overweight rating on the shares. The firm adjusted price targets in the bi...
Xencor Inc. (XNCR) announced an update on their ongoing clinical study. Claim 50% Off TipRanks Premium and Invest with Confidence Unlock hedge-fund level data...
Xencor (XNCR) just secured a new U.S. patent that effectively adds about three extra years to its Ultomiris royalty stream, a material boost that could help smo...
